(c) The finding that Irf4−/− preB-I cells respond preferentially to IL-7 over TSLP presents a possible explanation, why mouse models of BCP-ALL acquire Jak3 mutations, and human Ph-like ALL typically harbors Jak2 mutations. The gene discussed is IRF4; the disease is acute lymphoblastic leukemia.